Target intelligence / Profile preview

RNA, U2 small nuclear 53, pseudogene (RNU2-53P)

Target: RNU2-53P
Molecular classification: Other (Pseudogene, RNA molecule)

Overview

The target "RNA, U2 small nuclear 53, pseudogene" (RNU2-53P) is annotated as a pseudogene encoding a copy of U2 small nuclear RNA (U2 snRNA), but there is no evidence it is expressed or functional. Pseudogenes are generally non-functional genomic sequences that are not translated into proteins and do not play a direct role in biological processes, but can sometimes regulate gene expression or evolve new functions. There is no indication in scientific literature or major gene databases that RNU2-53P is transcribed or plays a role in disease, nor is there any evidence that it is a therapeutic target or a biomarker[1][3].

Biological functions

None (Pseudogene)

Beyond the preview

Go deeper on RNA, U2 small nuclear 53, pseudogene (RNU2-53P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 53, pseudogene (RNU2-53P).

Explore the full profile